← All companies

FULC

Fulcrum Therapeutics, Inc.

FULC Nasdaq Pharmaceutical Preparations EDGAR ↗

$3.71

+0.13 +3.63%

Key statistics

from XBRL data in SEC filings

Market cap

$283M

Revenue (TTM)

$0.00

Net income (TTM)

-$85.0M

EPS (TTM)

$-1.21

P/E ratio

—

Dividend yield

—

Free cash flow

-$60.4M

Cash

$48.5M

Total assets

$324M

Gross margin

—

52-week range

$2.83 – $15.74

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Shareholder vote results Jun 25, 2026 8-K Director or officer change Jun 11, 2026 8-K Exit or disposal costs; Other events Jun 4, 2026 8-K Other events Jun 1, 2026 10-Q Quarter ended 2026-03-31 Apr 27, 2026 8-K Terminated a material agreement; Results of operations (earnings release); Director or officer change Apr 27, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Results of operations (earnings release) Feb 24, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Entered a material agreement; Other events Dec 11, 2025 8-K Regulation FD disclosure; Other events Dec 8, 2025 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Results of operations (earnings release) Oct 29, 2025 8-K Regulation FD disclosure Aug 28, 2025 10-Q Quarter ended 2025-06-30 Jul 29, 2025 8-K Results of operations (earnings release); Other events Jul 29, 2025 8-K Shareholder vote results Jun 27, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 8-K Terminated a material agreement Mar 4, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release) Feb 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Terminated a material agreement Dec 23, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Director or officer change Nov 12, 2024 8-K Exit or disposal costs Sep 24, 2024 8-K Other events Sep 12, 2024 8-K Unregistered sale of equity Aug 22, 2024 10-Q Quarter ended 2024-06-30 Jul 31, 2024 8-K Results of operations (earnings release) Jul 31, 2024 8-K Director or officer change; Shareholder vote results Jun 17, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Entered a material agreement; Results of operations (earnings release) May 13, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release) Feb 27, 2024 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 7, 2023